Bio Protocol

Bio Protocol

Info

Name
Bio Protocol
Symbol
BIO
Network
Ethereum
Market Cap
$56M
Total Supply
2.96B
Circulating Supply
2.15B
Holders
11,233
Volume (24h)
$49K
+224.82%
Trades (24h)
413
+192.91%
Traders (24h)
88
+60.00%
All-Time High
$0.75
All-Time Low
$0.0165
Liquidity
$354K
Created (~2 yr old)
May 2024

About

BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP). The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity. The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.

FAQ

The market capitalization of BIO is $56M as of Aug 19, 2026.

Market capitalization is calculated by multiplying the current price of BIO by its circulating supply. It reflects the overall value of the token in the market and helps gauge its relative size compared to other cryptocurrencies.

The daily trading volume of BIO is $49K as of Aug 19, 2026.

Trading volume can fluctuate based on market conditions, investor activity, and overall demand for BIO.

The total supply of BIO is 2.96B.

The circulating supply, which represents the number of BIO currently available in the market, is 2.15B as of Aug 19, 2026.

BIO can be bought and traded on a variety of cryptocurrency platforms, including Phantom!

Pricing information is provided for informational purposes only and is not financial advice. Market data is provided by third parties and Phantom makes no representation as to the accuracy of the information.

Pricing information is provided for informational purposes only and is not financial advice. Market data is provided by third parties and Phantom makes no representation as to the accuracy of the information.